Purpose: This study compares the bone formation ability of tricalcium phosphate (TCP) with and without recombinant human bone morphogenetic protein-2 (rhBMP-2) and assesses TCP as a carrier of rhBMP-2. Methods: Bilateral round defects (diameter: 8.0 mm) were formed in the cranium of eight New Zealand white rabbits. The defects were grafted with TCP only (control group) or with rhBMP-2-coated TCP (experimental group). The animals were sacrificed at 1st week, 2nd week, 4th week, and 8th week postoperatively; two rabbits sacrificed each time. The skulls were harvested and subjected to radiographic and histological examination. Results: Radiologic evaluation showed faster bone remodeling in the experimental group than in the control group. Histologic evaluation (H&E, Masson's trichrome stain) showed rapid bone formation, remodeling and calcification in the 1st and 2nd week in the experimental group. Immunohistochemical evaluation showed higher expression rate of osteoprotegerin, receptor activator of nuclear factor κB ligand, and receptor activator of nuclear factor κB in the experimental group at the 1st and 2nd week than in the control group. Conclusion: rhBMP-2 coated TCP resulted in rapid bone formation, remodeling, and calcification due to rhBMP-2's osteogenic effect. TCP performed properly as a carrier for rhBMP-2. Thus, the use of an rhBMP-2 coating on TCP had a synergic effect on bone healing and, especially, bone remodeling and maturation.
Introduction
Defects in the maxillofacial skeleton generally are reconstructed with autogenous bone grafts [1] . Although autogenous bone performs best, its supply is limited. Bone harvesting at donor sites, moreover, incurs surgical stress and complications such as pain, bleeding and postoperative infection. To obviate the need for graft harvesting with its accompanying morbidity, bone substitutes and bone production via bioengineering are much sought-after alternatives. Ideally, bone grafts should be non-immunogenic and non-inflammatory, and should allow for rapid osteoinductivity, rapid osteoconductivity and rigid osteointegration [2, 3] .
Necessary for bone tissue formation at defect sites are osteogenic cells that induce it, a scaffold that can accommodate the proliferation and differentiation of cells at appropriate locations, and the osteoinductive growth factors that stimulate its differentiation induction. The osteoinductive growth factors include bone morphogenetic proteins (BMPs), transforming growth factors (TGF-β), insulin-like growth factor and others, among which BMPs are known to be the most effective [4] [5] [6] . BMPs, first noted by Urist [7] in 1965, have been investigated for their bone-growth-inducing properties. Specifically, BMPs can induce differentiation of mesenchymal cells and stem cells into osteoblasts and chondroblasts, as well as induce ectopic bone formation in soft tissue [8] [9] [10] . BMPs are also important in embryogenesis at bone fracture sites. BMPs induce new bone chiefly via the endochondral pathway.
BMPs released from a carrier initially induce formation of cartilage tissue around that carrier, which tissue gradually is replaced by bone [11] . Happily, it is expected that therapeutic application of recombinant human BMP-2 (rhBMP-2) in bone generation and augmentation will become possible [12] [13] [14] .
Tricalcium phosphate (Ca3(PO4)2; TCP), a synthetic, biodegradable bone-promoting and replacement biomaterial, has been extensively investigated for the repair of various shapes and sizes of bone defect caused by trauma, tumor resection or skeletal abnormalities, owing to its good biocompatibility and osteointegrative properties [15] . TCP is generally regarded as highly osteoconductive but not osteoinductive [16] [17] [18] [19] [20] . In the present study, we used TCP as a non-immunogenic, inorganic carrier for rhBMP-2, which has osteoinductive properties sufficient for realization of composite biomaterial. We studied osteoinduction in rabbit calvarial bone defects, comparing an experimental group treated with rhBMP-2-coated TCP with a control group (treated with TCP only). We compared the bone formation capability of TCP with and without rhBMP-2 and assessed TCP as an rhBMP-2 carrier.
Materials and Methods

Animals and group design
Eight New Zealand adult female rabbits older than 6 months, weighing between 2.5 and 3.5 kg, were used in the study. The animals were housed individually in stand- and sterile conditions. After a healing period of 4 weeks, an operation was performed on the cranium. In preparation, the dorsal area of the cranium was shaved and the surgical field was prepared with iodine solution. A midline incision was performed on the skull, and the periosteum was reflected laterally, exposing the parietal bones. Two symmetrical, 8-mm-wide bone defects were formed using a round bur under constant irrigation. Special care was taken to avoid injury to the dura (Fig. 1) .
The left defects (the experimental group) were grafted with rhBMP-2-coated TCP, and the right defects (the control group) with TCP only. After adequate hemostasis, the peri- 
Micro-computed tomography analysis
At each time point (1st week, 2nd week, 4th week, 8th week), the calvaria of two rabbits were scanned by micro-computed tomography (μCT; FLEX TM for flatform
; GMI, Northridge, CA, USA) horizontally, coronally and sagittally for measurement of the bone mineral density (BMD) at the 1st, 2nd, 4th, and 8th weeks (Fig. 2) . The BMD (mg/mL) was taken within the cylindrical region of interest (ROI), that is, the defect site, which showed a higher radiopacity on the μCT view.
Histology
Each specimen was fixed in a 10% formaldehyde solution, decalcified in formic acid for 48 hours, and embedded in paraffin. Serial cross-sections (5 μm) were cut through the large diameter of the defect and stained with hematoxylin-eosin (H&E) and Masson's trichrome, with which the cellular reaction and bone formation were evaluated. The slides were photographed using an image analysis system (Axiovision 4.3, Carl Zeiss, Jena, Germany).
Immunohistochemistry
Additional sections were mounted on glass slides for immunohistochemical analysis of the expressions of osteo- protegerin (OPG), the receptor activator of nuclear factor κB ligand (RANKL), and the receptor activator of nuclear factor κB (RANK) in the rabbit calvarial defects. These regulate osteoclast formation, differentiation, and activity.
The slides were coated with 4 μm on the dried slice, and maintained at 60 o C in an oven for an hour. After re- The immunohistochemical analysis was performed individually by two examiners blind to the treatment conditions. The relative staining intensity was assessed for each antibody. The samples were scored as follows: -= no immunoreactivity; + = weak but visible staining; ++ = moderate staining; +++ = strong staining intensity.
Results
Clinical observation
All of the animals recovered from the operation and healed without complications. Both the TCP and the rhBMP-2-coated TCP were well adapted into critical bone defects. In the experimental group, the graft material was rigid and well osseointegrated (Fig. 3) at the 1st and 2nd
weeks compared with the control group.
Micro-computed tomography analysis
The results of the BMD (mg/mL) measurement within the ROI for each group are listed in Table 1 . In both groups, the BMD value increased significantly from the 1st to the 8th week. The defects grafted with rhBMP-2-coated TCP; mg/mL) between the two groups through the 1st, 2nd and 4th weeks was higher than that (13.49 mg/mL) at the 8th week (Table 1) .
Histological findings 1) H&E staining
By the 1st week post-grafting, the control group had not formed bone, while the experimental group showed aspects of partial bone formation. By the 2nd weeks, bone formation within the control group was observed, along with advanced bone formation and mineralization in the experimental group. By the 4th weeks, both groups showed more advanced calcification, and by the 8th week, both presented complete calcification (Fig. 4) .
2) Masson's trichrome staining
Both groups in the 1st week showed a dark blue color indicating collagen and bone formation within the TCP, though the experimental group, in the 1st and 2nd weeks, more strongly. Both groups by the 4th weeks showed continuous activation of bone remodeling. Further, both groups manifested more specific aspects in the 8th weeks, specifically collagen and reddish-colored matured bone (Fig. 5) . 
Immunohistochemical findings 1) Osteoprotegerin
More specific OPG expression was observed in the experimental group than in the control group up to 2 weeks after grafting. Expression increased in both groups from the 1st to the 2nd weeks. The expression period was one week earlier in the experimental group. Expression was similar in both groups in the 4th week ( Table 2 , Fig. 6 ).
2) Receptor activator of nuclear factor κB ligand RANKL expression, related to osteoclast activity, was observed within the grafting material in both the experimental and control groups. The 1st and 2nd weeks after grafting, a specific increment of RANKL expression was observed in the experimental group; after the 4th and 8th weeks, a similar expression developed in the control group (Table   3 , Fig. 7 ).
3) Receptor activator of nuclear factor κB
The results for RANK expression were similar to those for OPG and RANKL. At the 1st and 2nd weeks after grafting, the experimental group showed more specific RANKL expression than the control group. The levels decreased by the 4th and 8th weeks, showing similar expression aspects between the two groups ( Table 4 , Fig. 8 ). The experimental group's expression of OPG, RANKL, and RANK were higher in the 1st and 2nd weeks but decreased to the level of the control group in the 4th and 8th weeks.
Discussion
A successful bone replacement material must be biocompatible, biodegradable and osteoconductive so as to attract cells to the defect site and promote the formation and Dietsh [29] argued that TCP, despite its porosity, is appropriate for mixed use in enhancing the maneuverability of osteogenetic substances such as BMPs, or for use in osteoconductive grafting materials, due to its high stability and abrasion resistance.
We selected TCP as the rhBMP-2 carrier because it is the most stable and appropriate material from the bone formation standpoint. We genetically engineered rhBMP-2 in E. coli and adsorbed it onto the TCP in a 100 μg/mL concentration. Pang et al. [30] Both calcium deficiency and ovariectomy can induce osteoporosis experimentally. However, while calcium deficiency does not seem to impair bone healing, the effect of ovariectomy is not known [32] . Ovariectomy decreases bone density in rabbits [33] . Therefore, we performed ovariectomies on rabbits to reduce BMD and induce osteoporosis, and used TCP, consisting of calcium and phosphate ions, to supply calcium to low-calcium bone. In this study, we grafted rhBMP-2-coated TCP and uncoated TCP onto left-and right-side defects to the skull of ovariectomized rabbits and evaluated the extents of bone formation and remodeling in radiological, μCT, histological and immunohistochemical analyses (OPG, RANKL, RANK).
In the μCT analysis results, the BMP group showed faster bone formation and remodeling than the control group in the 1st and 2nd weeks. Results were the same for the histological and immunohistochemical evaluations.
Collagen formation, early calcification, and mineralization occurred earlier in the rhBMP-2-coated TCP. OPG, RANKL, and RANK expressed at higher rates in the experimental group in the 1st and 2nd weeks. We can assume from these findings that vigorous bone remodeling occurs as osteoclast differentiation is accelerated by rhBMP-2 at the early stages. By the 4th and 8th weeks, there were no significant histological or immunohistochemical differences, because the graft material had sufficiently matured in both groups. In summation, TCP is crucial as the rhBMP-2 carrier, enabling the latter to effect bone formation, remodeling, and mineralization at the early stages.
Conclusion
In this study, we grafted either rhBMP-2-coated TCP or TCP only onto calvaria defects in ovariectomized rabbits and evaluated the extents of bone formation and remodeling.
1. In the radiological results, bone remodeled faster in the experimental group than the control group. The BMD estimation by μCT indicated especially high values for the experimental group at the 1st, 2nd, and 4th weeks.
However, there was no significant difference by the 8th week.
2. In the histological results (H&E, Masson's Trichrome stain), bone formed rapidly in the experimental group, with remodeling and calcification in the 1st and 2nd weeks.
However, there was no significant difference between the experimental and control groups in the 4th and 8th weeks.
3. In the immunohistochemical results, the OPG, RANKL, and RANK all expressed at higher rates in the experimental group at the 1st and 2nd weeks than the control group.
This implies that osteoblasts and osteoclasts are more active at the early stages.
Overall, rhBMP-2-coated TCP led to rapid bone formation, remodeling, and calcification, owing to rhBMP-2's osteogenic effect. TCP performed properly as a carrier for rhBMP-2. The use of rhBMP-2 coated TCP had a synergic effect on bone healing, and especially, bone remodeling and maturation. All of these findings suggest strongly that rhBMP-2-coated TCP is a promising clinical application advance in maxillofacial surgery for critical size defects.
